Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0000921895-17-001061

Options or other derivatives

  • Director acquired 20,507 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Eberwein Jeffrey E. Director 2017-04-11 Grant or award · Restricted Stock Unit +10,522 10,522 D
Eberwein Jeffrey E. Director 2017-04-11 Grant or award · Restricted Stock Unit +9,985 9,985 D
Loading xslF345X03/form410211002d_04142017.xml…